Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant clinical isolates of Acinetobacter baumannii from Cracow, Poland
- PMID: 24463791
- PMCID: PMC3936949
- DOI: 10.12659/MSMBR.889811
Co-occurrence of carbapenem and aminoglycoside resistance genes among multidrug-resistant clinical isolates of Acinetobacter baumannii from Cracow, Poland
Abstract
Background: Acinetobacter baumannii is a significant hospital pathogen, possessing a considerable degree of antimicrobial resistance. A. baumannii resistance to carbapenems and aminoglycosides is mostly conferred by class D OXA carbapenemases and aminoglycoside-modifying enzymes, respectively. The aim of this study was to determine the prevalence of selected genes encoding OXA carbapenemases and aminoglycoside-modifying enzymes in multidrug-resistant strains of A. baumannii.
Material and methods: The study included 61 carbapenem-resistant and aminoglycoside-nonsusceptible A. baumannii isolates, collected between 2009 and 2011 in Cracow, Poland. Selected resistance genes, including: blaOXA-51-like, blaOXA-23-like, blaOXA-40-like, blaOXA-58-like, aac(6')-Ih, aac(3)-Ia, aac(3)-IIa, aac(6')-Ib, aph(3')-Ia and aph(3')-VI, were detected by PCR method.
Results: The blaOXA-51-like genes were detected in all isolates, while acquired carbapenemase encoding genes were found in 96.7% of tested strains. Presence of blaOXA-40-like and blaOXA-23-like genes was observed among 65.6% and 27.9% of isolates, respectively. Assayed aminoglycoside resistance genes were found to harbor 98.4% of isolates. Among tested strains, we observed the following percentages of resistance determinants: aac(3)-Ia - 78.7%, aph(3')-VI - 78.7% and aph(3')-Ia - 27.9%. Analysis of co-occurrence of carbapenem and aminoglycoside resistance genes revealed the highest percentage of strains possessing blaOXA-40-like, aac(3)-Ia, and aph(3')-VI genes (44.3%).
Conclusions: The blaOXA-40-like and aac(3)-Ia/aph(3')-VI were the most prevalent genes encoding acquired OXA carbapenemases and aminoglycoside-modifying enzymes, respectively, among A. baumannii strains in Cracow, Poland. Genes conferring resistance to carbapenems and aminoglycosides coexisted in the clinical strains of A. baumannii. The phenomenon of A. baumannii resistance indicates the necessity of monitoring for the presence of the resistance genes.
Figures
Similar articles
-
Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.Exp Ther Med. 2016 Dec;12(6):3642-3652. doi: 10.3892/etm.2016.3828. Epub 2016 Oct 20. Exp Ther Med. 2016. PMID: 28101158 Free PMC article.
-
Analysis of blaCHDL Genes and Insertion Sequences Related to Carbapenem Resistance in Acinetobacter baumannii Clinical Strains Isolated in Warsaw, Poland.Int J Mol Sci. 2021 Mar 2;22(5):2486. doi: 10.3390/ijms22052486. Int J Mol Sci. 2021. PMID: 33801221 Free PMC article.
-
Coexistence of genes encoding aminoglycoside modifying enzymes among clinical Acinetobacter baumannii isolates in Ahvaz, Southwest Iran.Acta Microbiol Immunol Hung. 2019 Dec 13;67(1):33-41. doi: 10.1556/030.66.2019.042. Acta Microbiol Immunol Hung. 2019. PMID: 31833384
-
A systematic review: the current status of carbapenem resistance in East Africa.BMC Res Notes. 2018 Aug 31;11(1):629. doi: 10.1186/s13104-018-3738-2. BMC Res Notes. 2018. PMID: 30170613 Free PMC article.
-
Acinetobacter baumannii: A multidrug-resistant pathogen, has emerged in Saudi Arabia.Saudi Med J. 2023 Aug;44(8):732-744. doi: 10.15537/smj.2023.44.8.20230194. Saudi Med J. 2023. PMID: 37582561 Free PMC article. Review.
Cited by
-
Carbapenemase genes distribution in clonal lineages of Acinetobacter baumannii: a comprehensive study on plasmids and chromosomes.Front Cell Infect Microbiol. 2023 Dec 1;13:1283583. doi: 10.3389/fcimb.2023.1283583. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38106472 Free PMC article.
-
Whole genome analysis revealed the role of blaOXA-23 and blaOXA-66 genes in carbapenem resistance of Acinetobacter baumannii strains.Pathog Glob Health. 2025 Feb-Mar;119(1-2):10-21. doi: 10.1080/20477724.2024.2442194. Epub 2024 Dec 19. Pathog Glob Health. 2025. PMID: 39699991
-
High Prevalence of Virulence and blaOXA Genes Encoding Carbapenemases Among Acinetobacter baumannii Isolates from Hospitalised Patients in Three Regions of Poland.Pathogens. 2025 Jul 24;14(8):731. doi: 10.3390/pathogens14080731. Pathogens. 2025. PMID: 40872241 Free PMC article.
-
Acinetobacter baumannii Infections in Times of COVID-19 Pandemic.Pathogens. 2021 Aug 10;10(8):1006. doi: 10.3390/pathogens10081006. Pathogens. 2021. PMID: 34451470 Free PMC article. Review.
-
Prevalence of carbapenemases among high-level aminoglycoside-resistant Acinetobacter baumannii isolates in a university hospital in China.Exp Ther Med. 2016 Dec;12(6):3642-3652. doi: 10.3892/etm.2016.3828. Epub 2016 Oct 20. Exp Ther Med. 2016. PMID: 28101158 Free PMC article.
References
-
- Garnacho-Montero J, Amaya-Villar R. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr Opin Infect Dis. 2010;23:332–39. - PubMed
-
- Towner KJ. Acinetobacter: an old friend, but a new enemy. J Hosp Infect. 2009;73:355–63. - PubMed
-
- Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5:939–51. - PubMed
-
- Neonakis IK, Spandidos DA, Petinaki E. Confronting multidrug-resistant Acinetobacter baumannii: a review. Int J Antimicrob Agents. 2011;37:102–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical